RAF1 deficiency causes a lethal syndrome that underscores RTK signaling during embryogenesis
Abstract Somatic and germline gain‐of‐function point mutations in RAF, one of the first oncogenes to be discovered in humans, delineate a group of tumor‐prone syndromes known as the RASopathies. In this study, we document the first human phenotype resulting from the germline loss‐of‐function of the...
| Hlavní autoři: | , , , , , , , , , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
Springer Nature
2023-04-01
|
| Edice: | EMBO Molecular Medicine |
| Témata: | |
| On-line přístup: | https://doi.org/10.15252/emmm.202217078 |